Amphastar to Report Q3 2026 Results After Close on November 5
RANCHO CUCAMONGA – October 29, 2026 -- Amphastar Pharmaceuticals (NASDAQ: AMPH) will publish results for the third quarter ended September 30, 2026, after the market closes on Thursday, November 5, 2026.
Amphastar schedules a 2:00 p.m. Pacific call to discuss the quarter
Management will hold a conference call at 2:00 p.m. Pacific Time on the same day. Participants can dial 877-407-0989 toll-free or 201-389-0921 from outside the United States, ten minutes before the start. A webcast of the call will run on the Investors page of the company website, and a replay will be posted within 24 hours of the call's end.
BAQSIMI sales sustainability is a named risk factor
In its forward-looking statements, Amphastar states there is no guarantee that its sales strategies will succeed or that it will continue to see significant sales of BAQSIMI. The company's trademarked portfolio also includes Primatene MIST, Amphadase and Cortrosyn.